Adding a PD-1 inhibitor to PARP inhibitor maintenance therapy failed to slow progression or improve survival in newly ...

The efficacy of rucaparib plus nivolumab was compared with rucaparib monotherapy as maintenance treatment for ovarian cancer.

Most of the world’s biggest news website saw strong growth in July in what was a bumper month for news. July saw an assassination attempt against Donald Trump, Joe Biden announcing he would not ...

This content was published on Sep 18, 2024 The ailing solar company Meyer Burger is attempting to break free with a new restructuring program. The CEO is leaving the company. Numerous employees ...